By Editor , 18 September 2026 ReEmerge Exits Stealth With $37M Series A for Brain Injury Therapy Edina, Minn. – September 18, 2026 -- ReEmerge, Inc. has closed an oversubscribed $37 million Series A financing and exited stealth mode to advance a novel therapy targeting chronic cognitive impairment caused by traumatic brain injury (TBI).
